New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 3, 2013
05:57 EDTSLV, MYGNStocks with implied volatility movement; SLV MYGN
Stocks with implied volatility movement; iShares Silver Trust (SLV) 30, Myriad Genetics (MYGN) 77 according to iVolatility.
News For SLV;MYGN From The Last 14 Days
Check below for free stories on SLV;MYGN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
April 15, 2014
06:02 EDTSLViShares Silver Trust overall implied volatility at 25; 26-week average is 29
Subscribe for More Information
April 14, 2014
05:57 EDTSLViShares Silver Trust overall implied volatility at 25; 26-week average is 30
Subscribe for More Information
05:56 EDTSLViShares Silver Trust implied volatility of 24 at lower end of index mean range
April 11, 2014
05:54 EDTSLViShares Silver Trust overall implied volatility at 25; 26-week average is 30
April 10, 2014
05:53 EDTSLViShares Silver Trust overall implied volatility at 25; 26-week average is 30
Subscribe for More Information
April 9, 2014
11:57 EDTSLVStocks with call strike movement; AA SLV
Subscribe for More Information
06:03 EDTSLViShares Silver Trust overall implied volatility at 25; 26-week average is 30
Subscribe for More Information
April 8, 2014
05:59 EDTSLViShares Silver Trust overall implied volatility at 24; 26-week average is 30
Subscribe for More Information
April 7, 2014
16:34 EDTMYGNMyriad Genetics submits premarket approval to FDA for BRACAnalysis
Subscribe for More Information
11:09 EDTMYGNMyriad Genetics advises prior BRACAnalysis news release be disregarded
Myriad Genetics advised that readers should disregard the news release, "Myriad Genetics Submits Premarket Approval to FDA for BRACAnalysis" issued April 7 by the company over GlobeNewswire.
10:16 EDTMYGNMyriad Genetics has a conference call hosted by JPMorgan
Subscribe for More Information
06:18 EDTSLViShares Silver Trust overall implied volatility at 24; 26-week average is 30
Subscribe for More Information
05:48 EDTMYGNMyriad Genetics submits premarket approval to FDA for BRACAnalysis
Subscribe for More Information
April 4, 2014
11:07 EDTMYGNMyriad Genetics price target raised to $42 from $34 at Piper Jaffray
Piper Jaffray raised its price target for Myriad Genetics shares to $42 to reflect CMS' recent decision to increase BRCA reimbursement. The firm keeps an Overweight rating on the stock.
10:02 EDTMYGNOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
06:48 EDTMYGNMyriad Genetics upgraded to Buy from Neutral at Mizuho
Subscribe for More Information
06:46 EDTMYGNMyriad Genetics upgraded to Buy from Neutral at Mizuho
05:52 EDTSLViShares Silver Trust overall implied volatility at 25; 26-week average is 30
April 3, 2014
07:37 EDTMYGNMyriad Genetics price target raised to $40 from $28 at Mizuho
Mizuho raised Myriad's price target to $40 from $28 following the better than expected CMS pricing for BRCA testing. Shares are Neutral rated.
05:52 EDTSLViShares Silver Trust overall implied volatility at 24; 26-week average is 30
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use